Latest AI and machine learning research in diabetes for healthcare professionals.
Modern machine learning produces models that are impossible for users or developers to fully understand -- raising concerns about trust, oversight and human dignity. Transparency and explainability methods aim to provide some help in understanding models, but it remains challenging for developers to design explanations that are understandable to target users and effective for their purpose. Emer...
Deep learning has emerged as a transformative approach for solving complex pattern recognition and object detection challenges. This paper focuses on the application of a novel detection framework based on the RT-DETR model for analyzing intricate image data, particularly in areas such as diabetic retinopathy detection. Diabetic retinopathy, a leading cause of vision loss globally, requires accu...
Healthcare decision-making requires not only accurate predictions but also insights into how factors influence patient outcomes. While traditional M...
Reinforcement learning (RL) has demonstrated success in automating insulin dosing in simulated type 1 diabetes (T1D) patients but is currently unabl...
The prevalence of ocular illnesses is growing globally, presenting a substantial public health challenge. Early detection and timely intervention ar...
OBJECTIVE: To establish and validate a novel diabetic retinopathy (DR) risk-prediction model using a whole-exome sequencing (WES)-based machine learni...
Artificial Intelligence-Generated Content, a subset of Generative Artificial Intelligence, holds significant potential for advancing the e-health se...
Purpose: Diabetic retinopathy (DR) is a major cause of vision loss, particularly in India, where access to retina specialists is limited in rural ar...
The emergence of artificial intelligence (AI), particularly deep learning (DL), has marked a new era in the realm of ophthalmology, offering transfo...
Diabetic Retinopathy (DR) is a major cause of blindness worldwide, caused by damage to the blood vessels in the retina due to diabetes. Early detect...
The rapid integration of artificial intelligence (AI) in healthcare is revolutionizing medical diagnostics, personalized medicine, and operational e...
Overcoming biological barriers remains the paramount challenge for pulmonary mRNA therapeutics. Conventional approaches focus exclusively on passively...
This research paper presents a machine learning approach to predict bioactivity of compounds that can act as PPAR-gamma agonist, a critical target for...
Recent clinical trial data have shown that cell therapy holds curative potential for type-1 diabetes, however the large amounts of lab-grown cells req...
Analyzing whole tissue architecture remains challenging due to the inherent complexity of multicellular organization, variable morphology, and the lim...
Type 1 diabetes (T1D) is associated with microbial dysbiosis. While most research has focused on the gut microbiome, limited data address the role of ...
While extensive efforts have characterized lymphoid populations that contribute to pancreatic ‘insulitis’ in type 1 diabetes, significant gaps remain ...
Type 1 diabetes mellitus (T1DM) is the most common severe chronic disease in children and adolescents and requires life-long exogenous insulin treatme...
In type 2 diabetes (T2D), molecular pathways driving β cell failure are difficult to resolve with standard single cell analysis. Here we developed an ...
Polygenic Risk Scores (PRS) are emerging tools for predicting an individual’s genetic risk for complex diseases. However, their usefulness in clinical...